Table 2.
No. of patients | Percentage (%) | ||
---|---|---|---|
Sex | Female | 190 | 69 |
Male | 85 | 31 | |
Age, mean (range) | 56 (24–87) | ||
Hospital | 1 | 22 | 7.9 |
2 | 7 | 2.5 | |
3 | 48 | 17.3 | |
4 | 23 | 8.3 | |
5 | 19 | 7.2 | |
6 | 18 | 6.5 | |
7 | 43 | 15.5 | |
8 | 46 | 17.0 | |
9 | 49 | 17.7 | |
WHO performance status | 0 | 169 | 61.4 |
1 | 83 | 30.3 | |
2 | 14 | 5.1 | |
3 | 5 | 1.8 | |
4 | 0 | 0 | |
unknown | 4 | 1.4 | |
Alcohol use | 0 units/week | 108 | 39.4 |
1–4 units/week | 96 | 34.7 | |
5–10 units/week | 34 | 12.6 | |
11 or more units/week | 29 | 10.5 | |
Unknown | 8 | 2.9 | |
Cancer diagnosis | Breast | 127 | 46.2 |
Lung | 62 | 22.7 | |
Colorectal | 27 | 9.7 | |
Urogenital | 7 | 2.5 | |
Gynecological | 11 | 4.0 | |
Lymphoma | 17 | 6.1 | |
Other | 24 | 8.8 | |
Chemotherapy intent | Curative | 59 | 21.7 |
Adjuvant | 115 | 41.5 | |
Palliative | 76 | 27.8 | |
Neo-adjuvant | 18 | 6.5 | |
Unknown | 7 | 2.5 | |
Emetogenicity of chemotherapy | High | 101 | 37 |
Moderate (anthracycline) | 140 | 51 | |
Moderate (no anthracycline) | 34 | 12 | |
History of pregnancy emesis | 43 | 15.6 | |
History of motion sickness | 41 | 14.9 |
aThe two patients that dropped out before completing one study course were not included in the analyses